Larvol Delta - ASLAN-Pharmaceuticals-Announces-Acceptance-of-LateBreaking-Abstract-on-Eblasakimab-and-Neuronal-Itch-Mechanisms-for-Poster-Presentation-at-the-2022-Society-for-Investigative-Dermatology-Annual-Meeting

eblasakimab (ASLAN004) - ASLAN Pharma

https://www.globenewswire.com/news-release/2022/05/10/2439535/0/en/ASLAN-Pharmaceuticals-Announces-Acceptance-of-Late-Breaking-Abstract-on-Eblasakimab-and-Neuronal-Itch-Mechanisms-for-Poster-Presentation-at-the-2022-Society-for-Investigative-Derma.html

May 10, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next